Intracameral Bevacizumab Versus Sub-Tenon's Mitomycin C as Adjuncts to Trabeculectomy: 3-Year Results of a Prospective Randomized Study.

J Clin Med · 2021 · PMC8151253 · PMID 34064843

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely missed statistical significanceno p-value reported

The difference in IOP barely missed statistical significance 6 months after surgery in favor of the bevacizumab group ( Table 2 ).

also in 44 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.